MELISSA WESTCOTT: Open Payments
NPI 1023705696 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 71 payments from 17 companies in 2025. Trend: 2023 $668 · 2024 $1,034 · 2025 $1,857
Food & beverage: $1,857
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $368 |
| Amgen Inc. | 7 | $337 |
| ABBVIE INC. | 12 | $225 |
| AstraZeneca Pharmaceuticals LP | 8 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 6 | $118 |
| Exact Sciences Corporation | 4 | $103 |
| Lilly USA, LLC | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Boston Scientific Corporation | 2 | $38 |
Products named: AIRSUPRA, NURTEC ODT, VRAYLAR, REPATHA, ZAVZPRET, EVENITY, Kerendia, REXULTI.
Industry payments across CO — which companies pay providers there.
